Biomineralization of calcium disilicide in porous polycaprolactone scaffolds

被引:28
作者
Seregin, Vladimir V. [1 ]
Coffer, Jeffery L. [1 ]
机构
[1] Texas Christian Univ, Dept Chem, Ft Worth, TX 76129 USA
关键词
calcium disilicide; polycaprolactone; calcification; tissue engineering scaffold;
D O I
10.1016/j.biomaterials.2006.04.031
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
The incorporation of CaSi2 grains within a polycaprolactone (PCL) framework results in bioactive and biodegradable scaffolds which may be used in bone tissue regeneration. Porous PCL scaffolds were prepared via a combination of salt-leaching and microemulsion methods. To provide markedly different structural environments for the inorganic phase, calcium disilicide powder was either added to a mixed-composition porogen during a given scaffold preparation, or alternatively added to pre-formed scaffolds. Selective fluorescent labeling, scanning electron microscopy (SEM), and energy dispersive X-ray (EDX) analysis were employed to assess scaffold calcification in vitro. The process of CaSi2/PCL scaffold calcification under zero bias, during which calcium phosphate growth is significantly dependent on the structural degradation of CaSi2 grains, has a similar mechanism as the calcium phosphate growth on bioactive glasses/ceramics. The biomineralization of these scaffolds is initiated solely by the silicide phase and can be accelerated by the degradation of the polymer matrix. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:4745 / 4754
页数:10
相关论文
共 31 条
[1]   Dissolution of different forms of partially porous silicon wafers under simulated physiological conditions [J].
Anderson, SHC ;
Elliott, H ;
Wallis, DJ ;
Canham, LT ;
Powell, JJ .
PHYSICA STATUS SOLIDI A-APPLICATIONS AND MATERIALS SCIENCE, 2003, 197 (02) :331-335
[2]   CHEMICAL-BOND AND ELECTRONIC STATES IN CALCIUM SILICIDES - THEORY AND COMPARISON WITH SYNCHROTRON-RADIATION PHOTOEMISSION [J].
BISI, O ;
BRAICOVICH, L ;
CARBONE, C ;
LINDAU, I ;
IANDELLI, A ;
OLCESE, GL ;
PALENZONA, A .
PHYSICAL REVIEW B, 1989, 40 (15) :10194-10209
[3]   Ten years' experience with alendronate for osteoporosis in postmenopausal women [J].
Bone, HG ;
Hosking, D ;
Devogelaer, J ;
Tucci, JR ;
Emkey, RD ;
Tonino, RP ;
Rodriguez-Portales, JA ;
Downs, RW ;
Gupta, J ;
Santora, AC ;
Liberman, UA .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (12) :1189-1199
[4]  
BRONZINO JD, 2000, BIOMED ENG HDB
[5]   Bioactive silicon structure fabrication through nanoetching techniques [J].
Canham, LT .
ADVANCED MATERIALS, 1995, 7 (12) :1033-+
[6]   SILICON . A POSSIBLE FACTOR IN BONE CALCIFICATION [J].
CARLISLE, EM .
SCIENCE, 1970, 167 (3916) :279-&
[7]   ELECTRONIC AND STRUCTURAL-PROPERTIES OF CASI2 [J].
FAHY, S ;
HAMANN, DR .
PHYSICAL REVIEW B, 1990, 41 (11) :7587-7592
[8]   Nanotube bundles from calcium disilicide: A density functional theory study [J].
Gemming, S ;
Seifert, G .
PHYSICAL REVIEW B, 2003, 68 (07)
[9]  
Hench LarryL., 1993, INTRO BIOCERAMICS
[10]   Alendronate - A review of its pharmacological properties and therapeutic efficacy in postmenopausal osteoporosis [J].
Jeal, W ;
Barradell, LB ;
McTavish, D .
DRUGS, 1997, 53 (03) :415-434